Table 2. Clinicopathological parameters of EAC patients.
| Clinical characteristic | N | % |
| Age (years) | ||
| ≤65 | 36 | 46.15 |
| > 65 | 42 | 53.85 |
| Gender | ||
| Male | 67 | 85.90 |
| Female | 11 | 14.10 |
| Grade | ||
| G1-2 | 29 | 54.72 |
| G3 | 24 | 45.28 |
| T classification | ||
| T1 - T2 | 30 | 45.45 |
| T3-T4 | 36 | 54.55 |
| N classification | ||
| N0 | 19 | 29.23 |
| N1-3 | 46 | 70.77 |
| M classification | ||
| M0 | 50 | 90.91 |
| M1 | 5 | 9.09 |
| UICC stage | ||
| I-II stage | 30 | 48.39 |
| III-IV stage | 32 | 51.61 |
| Survival status | ||
| Alive | 40 | 51.28 |
| Deceased | 38 | 48.72 |
| Mean follow-up time (month) | 19.65 |
Footnotes: EAC, esophageal adenocarcinoma; UICC, Union for International Cancer Control; T, tumor; N, node; M, metastasis.